These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients]. Xu YH, Chen ZW, Ye XY, Lu S. Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920 [Abstract] [Full Text] [Related]
4. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor]. Dai XF, Yu J, Liu L, Wu G. Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944 [Abstract] [Full Text] [Related]
5. [Clinical tolerance test of recombinant human thrombopoietin]. Zhao Y, Jiang J, Jiao L. Zhonghua Yi Xue Za Zhi; 2001 Dec 25; 81(24):1508-11. PubMed ID: 16200777 [Abstract] [Full Text] [Related]
6. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia]. Wang XY, Feng FY, Song ST, Wang HQ, Zhang MH, Liu J, Liu XY, Xu LG, Zhang Y. Zhonghua Zhong Liu Za Zhi; 2005 Jun 25; 27(6):373-6. PubMed ID: 16117903 [Abstract] [Full Text] [Related]
7. [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia]. Lei W, Liang J, Chen WG, Ma XZ, Xu M, Du LL. Zhonghua Zhong Liu Za Zhi; 2006 Jul 25; 28(7):542-4. PubMed ID: 17147124 [Abstract] [Full Text] [Related]
10. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients]. Li Q, Ye M, Xiao W, Zhu J, Zhang S. Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun 25; 32(7):1064-6. PubMed ID: 22820601 [Abstract] [Full Text] [Related]
14. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience. Angiolillo AL, Davenport V, Bonilla MA, van de Ven C, Ayello J, Militano O, Miller LL, Krailo M, Reaman G, Cairo MS, Children's Oncology Group. Clin Cancer Res; 2005 Apr 01; 11(7):2644-50. PubMed ID: 15814645 [Abstract] [Full Text] [Related]
15. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer. Vadhan-Raj S, Verschraegen CF, Bueso-Ramos C, Broxmeyer HE, Kudelkà AP, Freedman RS, Edwards CL, Gershenson D, Jones D, Ashby M, Kavanagh JJ. Ann Intern Med; 2000 Mar 07; 132(5):364-8. PubMed ID: 10691586 [Abstract] [Full Text] [Related]
16. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura]. Zhao YQ, Wang QY, Zhai M, Xu J, Chen XQ, Liu WL, Zhang M, Song SJ, Wang JM, Meng FY, Shan YD. Zhonghua Nei Ke Za Zhi; 2004 Aug 07; 43(8):608-10. PubMed ID: 15355668 [Abstract] [Full Text] [Related]
17. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study. Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV, Fay J. Bone Marrow Transplant; 2001 Feb 07; 27(3):261-8. PubMed ID: 11277173 [Abstract] [Full Text] [Related]
18. [A clinical comparative study on treatment of severe newly diagnosed immune thrombocytopenia by recombinant human thrombopoietin combined with glucocorticoid]. Gu SY, Zhuang JL, Zou SH, Li F, Wang ZM, Cheng YF, Wang WG, Cheng ZX, Yuan L, Cheng LY, Wei Z. Zhonghua Xue Ye Xue Za Zhi; 2013 Oct 07; 34(10):883-6. PubMed ID: 24171964 [Abstract] [Full Text] [Related]
19. [The efficacy and mechanism of rhIL-11 in the management of chemotherapy-induced thrombocytopenia in acute leukemia]. Cui XL, Wang L, Gao J, Qin P, Shi Y, Peng J, Hou M. Zhonghua Xue Ye Xue Za Zhi; 2005 Jun 07; 26(6):345-7. PubMed ID: 16185478 [Abstract] [Full Text] [Related]